Platelet-rich plasma and platelet-rich fibrin combined with arthrocentesis in temporomandibular osteoarthritis
Abstract
Introduction: Osteoarthritis of the temporomandibular joint is a common disease that causes pain and functional limitation. In its treatment, arthrocentesis and intra-articular infiltrations of different substances have been proposed as an accessible, safe and minimally invasive option.
Objective: To evaluate the efficacy of platelet-rich plasma and injectable platelet-rich fibrin combined with arthrocentesis in the treatment of patients with temporomandibular joint osteoarthritis.
Methods: A quasi-experimental study was carried out in patients with osteoarthritis of the temporomandibular joint at the Manuel Ascunce Domenech University Hospital and the Martín Chang Puga General Hospital, in the period from September 2023 to September 2024. The study universe consisted of 43 patients and the non-probabilistic sample was made up of 24 patients, who were distributed in two groups of equal quantity. Arthrocentesis was performed in all patients and platelet-rich plasma (Group A) and platelet-rich fibrin (Group B) were subsequently infiltrated. The variables considered in the study were age, sex, pain, and mouth opening.
Results: The most affected age group was 51 to 60 years old with (41.6 %) n=10 and the female sex with (91.6 %) n=22 of the sample. Patients treated with platelet-rich fibrin showed significant differences in pain relief compared to those who received platelet-rich plasma (p=001). Mouth opening improved in all patients, there were no significant differences between the study groups, however, patients in group B showed better results.
Conclusions: The most affected age group was 51 to 60 years old with (41.6 %) n=10 and the female sex with (91.6 %) n=22 of the sample. Patients treated with platelet-rich fibrin showed significant differences in pain relief compared to those who received platelet-rich plasma (p=001). Mouth opening improved in all patients, there were no significant differences between the study groups, however, patients in group B showed better results.
DeCS: REGENERATIVE MEDICINE; TEMPOROMANDIBULAR JOINT; OSTEOARTHRITIS; PLATELET-RICH FIBRIN; PLATELET-RICH PLASMA.
Downloads
References
1. Namvar MA, Afkari BF, Moslemkhani C, Mansoori K, Dadashi M. The Relationship between Depression and Anxiety with Temporomandibular Disorder Symptoms in Dental Students. Maedica (Bucur) [Internet]. 2021 [citado 10 febrero 2025];16(4):590-594. Disponible en: http://doi.org/10.26574/maedica.2021.16.4.590
2. Matos Frometa K, Ramírez Ley RM, La O Salas NO, Barata Garces I, Liranza Rodriguez M. Terapias físicas en pacientes con trastornos de la articulación temporomandibular. Medisan [Internet]. 2021 [citado 11 Feb 2025]; 25(3):580-595. Disponible en: https://www.redalyc.org/articulo.oa?id=36846786700236
3. Peña G, Díaz W, Flores G, Marinkovic K, Romo F, Schulz R. Concordancia entre los criterios diagnósticos RDC/TMD y su actualización DC/TMD, aplicados a la patología inflamatoria de la articulación temporomandibular. Rev clín de periodoncia implantol rehabil oral [Internet]. 2019 [citado 11 Feb 2025]; 12(2):70–73. Disponible en: http://doi.org/10.4067/S0719-01072019000200070
4. Mélou C, Pellen-Mussi P, Jeanne S, Novella A, Tricot-Doleux S, Chauvel-Lebret D. Osteoarthritis of the Temporomandibular Joint: A Narrative Overview. Medicina (Kaunas) [Internet]. 2022 [cited 2025 Feb 11];59(1). Disponible en: https://doi.org/10.3390/medicina59010008
5. Bayramoglu Z, Yavuz GY, Keskinruzgar A, Koparal M, Kaya GS. Does intra-articular injection of tenoxicam after arthrocentesis heal outcomes of temporomandibular joint osteoarthritis? A randomized clinical trial. BMC Oral Health [Internet]. 2023 [citado 19 enero 2025];23(1). Disponible en: https://doi.org/10.1186/s12903-023-02852-z
6. Al-Moraissi EA, Wolford LM, Ellis E, Neff A. La jerarquía de los diferentes tratamientos para los trastornos temporomandibulares artrógenos: un metanálisis en red de ensayos clínicos aleatorizados. J Cirugía craneomaxilofac [Internet]. 2020 [citado 11 Feb 2025]; 48(1):9-23. Disponible en: https://doi.org/10.1016/j.jcms.2019.10.004
7. Turosz N, Chęcińska K, Chęciński M, Lubecka K, Bliźniak F, Chlubek D; et al. Temporomandibular Joint Injections and Lavage: An Overview of Reviews. J Clin Med [Internet]. 2024 [citado 11 febrero 2025]; 13(10):2855. Disponible en: https://doi.org/10.3390/jcm13102855
8. Cardoneanu A, Macovei LA, Burlui AM, Mihai IR, Bratoiu I, Rezus II; et al. Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration. Int J Mol Sci [Internet]. 2022 [citado 15 enero 2025];24(1):171. Disponible en: http://doi.org/10.3390/ijms24010171
9. Manafikhi M, Ataya J, Heshmeh O. Evaluation of the efficacy of platelet rich fibrin (I-PRF) intra-articular injections in the management of internal derangements of temporomandibular joints - a controlled preliminary prospective clinical study. BMC Musculoskelet. Disord [Internet]. 2022 [citado 15 enero 2025];23(1):454. Disponible en: https://doi.org/10.1186/s12891-022-05421-7
10. Travezán-Moreyra M, Aguirre-Aguilar A, Arbildo-Vega H. Efecto de la Fibrina Rica en Plaquetas en la Curación de los Tejidos Blandos de Alveolos Post Exodoncia Atraumática. Un Ensayo Clínico Controlado Aleatorizado Cruzado a Ciego Simple. Int J Odontostomat [Internet]. 2021 [citado 11 Feb 2025]; 15(1):240-247. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-381X2021000100240&lng=es
11. Arbildo-Vega H, Alay-Baca V, Giribaldi-Ugáz G, Vásquez-Rodrigo H. Efectividad de los concentrados plaquetarios en el tratamiento de los desórdenes temporomandibulares. Rev cuba estomatol [Internet]. 2021[citado11 Feb 2025];58(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci
12. Ghoneim I, Mansour A, Elmaghraby A, Abdelsameaa E. Tratamiento del desplazamiento del disco de la articulación temporomandibular mediante artrocentesis combinada con fibrina rica en plaquetas inyectable versus artrocentesis sola. Revista de ciencias dentales [Internet]. 2022 [citado 11 Feb 2025 ];17(1):468–475. Disponible en: https://doi.org/10.1016/j.jds.2021.07.027
13. Sharma P, Aurora JK, Dubey KN, Tandon P, Tiwari S. Un análisis comparativo entre las inyecciones intraarticulares de fibrina rica en plaquetas inyectable frente al plasma rico en plaquetas en el tratamiento de los trastornos temporomandibulares: un ensayo controlado aleatorizado. Natl J Maxillofac Surg [Internet]. 2023 [citado 15 Ene 2025]; 14(2):249-255. Disponible en: http://doi.org/10.4103/njms.njms_498_21
14. WMA [Internet. Filadeofia: Asociación Médica Mundial; 2025 [actualización 2025; citado 2024 Dic 21]. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos; [aprox. 2]. Disponible en: http://www.redsamid.net/archivos/201606/2013-declaracion-helsinki-brasil.pdf
15. Abdelmoneim H, Teama U. Evaluation of Injectable platelet rich fibrin for the management of Tempromandibular joint internal derangement. Egypt Dent J [Internet]. 2020 [citado 21 diciembre 2024]; 66(2):883-91. Disponible en: https://edj.journals.ekb.eg/article_86118.html
16. Martínez-Blanco M, Bagán-José V, Fons-Antonio, Poveda-Roda R. Osteoartrosis de la articulación temporomandibular: Estudio clínico y radiológico de 16 pacientes. Med oral patol oralcir bucal [Internet]. 2004 [citado 5 Oct 2024];9(2):106-115. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-44472004000200002&lng=es.
17. Bera RN, Tiwari P. Evaluating the role of intra articular injection of platelet-rich fibrin in the management of temporomandibular joint osteoarthritis: A STROBE compliant retrospective study. Oral Surgery [Internet]. 2022 [citado 10 enero 2025];15(3):218-23. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/ors.12665
18. Nemeth A, Gurgel BV, Lowenstein A, Juliasse L, Siroma RS, Zhu Z; et al. Does Liquid/Injectable Platelet-Rich Fibrin Help in the Arthrocentesis Treatment of Temporomandibular Joint Disorder Compared to Other Infusion Options? A Systematic Review of Randomized Clinical Trials. Bioengineering (Basel) [Internet]. 2024 [citado 11 febrero 2025] ;11(3):247. Disponible en: http://doi.org/10.3390/bioengineering11030247
19. Sielski M, Chęcinska K, Chęcinski M, Sikora M. Fibrina rica en plaquetas inyectable (I-PRF) administrada a las cavidades de la articulación temporomandibular: una revisión exploratoria. J Clin Med [Internet]. 2023 [citado 11 Feb 2025];12(9):3326. Disponible en: http://doi.org/10.3390/jcm12093326
20. Anand A. The Clinical Efficacy of Injectable Platelet Rich Fibrin in the Treatment of Degenerative Temporomandibular Joint Disease. Nov Tech Arthritis Bone Res [Internet]. 2018 [citado 19 Nov 2024]; 3(1): 555606. Disponible en: http://doi.org/10.19080/NTAB.2018.03.555606
21. Mazzara Bou C, González Sarrión Ó. Artrocentesis de la articulación temporomandibular y corticoides. Revisión de la literatura. Rev Esp Cirug Oral y Maxilofac [Internet]. 2022 [citado 11 Feb 2025] ;44(1): 30-39. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-05582022000100030&lng=es
22. Zotti F, Albanese M, Rodella LF, Nocini PF. Platelet-Rich Plasma in Treatment of Temporomandibular Joint Dysfunctions: Narrative Review. Int J Mol Sci [Internet]. 2019 [citado 23 noviembre 2024] ;20(2):277. Disponible en: http://doi.org/10.3390/ijms20020277
23. Lin SL, Tsai CC, Wu SL, Ko SY, Chiang WF, Yang JW. Effect of arthrocentesis plus platelet-rich plasma and platelet-rich plasma alone in the treatment of temporomandibular joint osteoarthritis: A retrospective matched cohort study (A STROBE-compliant article). Medicine [Internet]. 2018 [citado 11 febrero 2025];97(16):e0477. Disponible en: http://doi.org/10.1097/MD.0000000000010477
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
14 julio 2025